Prakt. lékáren. 2012; 8(1): 28-30

New medicinal substances in extemporaneous prescription, part 13 - sotalol hydrochloride

Zbyněk Sklenář1,2, Kateřina Horáčková2
1 Farmakologický ústav, 1. LF UK, Praha
2 Lékárna Na Rohožníku, Praha

In some cases in pediatric practice it is impossible to use a registered commercial product because of dosage unavailability for children.

Sotalol-hydrochloride, used in therapy for arrhythmia, is available as a substance for extemporaneous preparation in pharmacies, thus it

is possible to create a formulation suitable for children and individual doses for them. The paper provides information on the properties

and use of sotalol-hydrochloride and presents examples of formulas suitable for use in pediatric practice.

Keywords: sotalol hydrochloride, antiarrhythmic agent, magistral preparation, pediatric dosage forms

Published: March 1, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Sklenář Z, Horáčková K. New medicinal substances in extemporaneous prescription, part 13 - sotalol hydrochloride. Praktické lékárenství. 2012;8(1):28-30.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Zákon č. 378/2007 Sb. o léčivech a o změnách některých souvisejících zákonů, ve znění pozdějších předpisů.
    2. Vyhl. č. 84/2008 Sb. o správné lékárenské praxi, bližších podmínkách zacházení s léčivy v lékárnách, zdravotnických zařízeních a u dalších provozovatelů a zařízení vydávajících léčivé přípravky.
    3. Smlouva o poskytování a úhradě léčivých přípravků, potravin pro zvláštní lékařské účely a zdravotnických prostředků. VZP. Dostupné z: http://www.vzp.cz/uploads/document/1293534715-Lxkxrny_p02.pdf (2. 9. 2011) [cit. 201109-18].
    4. Heinc P. Současný pohled na antiarytmika. Klin Farmakol Farm 2009; 23(2): 64-70.
    5. Kolektiv autorů. Remedia Compendium. 4., přeprac. a rozšíř. vyd. Praha: Panax Co, s. r. o, 2009: 946.
    6. Rao SO, Boramanand NK, Burton DA, Perry JC. Atrial tachycardias in young adults and adolescents with congenital heart disease: Conversion using single dose oral sotalol. Inter J Cardiol 2009; 136(3): 253-257. Go to original source... Go to PubMed...
    7. Wynn RL, Meiller TF, Crossley HL. Drug information handbook for dentistry. 15. ed. Ohio: Lexi-Comp 2009: 1593-1595.
    8. Rezepturhinweise: Sotalol. Dostupné z: http://www.pharmazeutische-zeitung.de/fileadmin/nrf/pdf/1-Sotalol.pdf [cit. 2011-10-20].
    9. Mikro-verze AISLP - Automatizovaný informační systém léčivých přípravků. [CD-ROM]. Ver. ČR 2011.1 pro MS Windows platná k 1. 1. 2011. Praha, 2011.
    10. Heinc P. Farmakoterapie fibrilace síní. Interv Akut Kardiol 2009; 8(1): 28-33.
    11. Läer S, Elshoff JP, Meibohm B, et al. Development of a safe and effective pediatric dosing regimen for sotalol based on population pharmacokinetics and pharmacodynamics in children with supraventricular tachycardia. J Am Coll Cardiol 2005; 46(7): 1322-1330. Go to original source... Go to PubMed...
    12. Maragn?s P, Tipple M, Fournier A. Effectiveness of oral sotalol for treatment of pediatric arrhythmias. Am J Cardiol 1992; 69(8): 751-754. Go to original source... Go to PubMed...
    13. Knudson JD, Cannon BC, Kim JJ, Moffett BS. High-dose sotalol is safe and effective in neonates and infants with refractory supraventricular tachyarrhythmias. Pediatr Cardiol 2011; 32(7): 896-903. Go to original source... Go to PubMed...
    14. Tanel RE, Walsh EP, Lulu JA, Saul JP. Sotalol for refractory arrhythmias in pediatric and young adult patients: initial efficacy and long-term outcome. Am Heart J 1995; 130(4): 791-797. Go to original source... Go to PubMed...
    15. Nahata MC, Morosco RS. Stability of sotalol in two liquid formulations at two temperatures. Ann Pharmacother 2003; 37(4): 506-509. Go to original source... Go to PubMed...
    16. Dupuis LL, James G, Bacola G. Stability of a sotalol hydrochloride oral liquid formulation. Can J Hosp Pharm 1988; 41(3): 121-23.

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.